Submission Details
| 510(k) Number | K020023 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 03, 2002 |
| Decision Date | February 28, 2002 |
| Days to Decision | 56 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
K020023 is an FDA 510(k) clearance for the DAKO MONOCLONAL MOUSE ANTI-HUMAN PROGESTERONE RECEPTOR, CLONE PGR 636, ANTIBODY FOR IMMUNOENZYMATIC STAINING, a Immunohistochemistry Assay, Antibody, Progesterone Receptor (Class II — Special Controls, product code MXZ), submitted by Dako Corp. (Carpinteria, US). The FDA issued a Cleared decision on February 28, 2002, 56 days after receiving the submission on January 3, 2002. This device falls under the Pathology review panel. Regulated under 21 CFR 864.1860.
| 510(k) Number | K020023 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 03, 2002 |
| Decision Date | February 28, 2002 |
| Days to Decision | 56 days |
| Submission Type | Traditional |
| Review Panel | Pathology (PA) |
| Summary | Summary PDF |
| Product Code | MXZ — Immunohistochemistry Assay, Antibody, Progesterone Receptor |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.1860 |